COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany.
Aged
Aged, 80 and over
Betacoronavirus
COVID-19
Coronavirus Infections
/ mortality
Extracorporeal Membrane Oxygenation
Female
Germany
/ epidemiology
Hospital Mortality
Humans
Intensive Care Units
Male
Middle Aged
Models, Statistical
Pandemics
Pneumonia, Viral
/ mortality
Respiration, Artificial
Retrospective Studies
SARS-CoV-2
Tertiary Healthcare
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
12
08
2020
accepted:
27
10
2020
entrez:
12
11
2020
pubmed:
13
11
2020
medline:
24
11
2020
Statut:
epublish
Résumé
Reported mortality of hospitalised Coronavirus Disease-2019 (COVID-19) patients varies substantially, particularly in critically ill patients. So far COVID-19 in-hospital mortality and modes of death under state of the art care have not been systematically studied. This retrospective observational monocenter cohort study was performed after implementation of a non-restricted, dynamic tertiary care model at the University Medical Center Freiburg, an experienced acute respiratory distress syndrome (ARDS) and extracorporeal membrane-oxygenation (ECMO) referral center. All hospitalised patients with PCR-confirmed SARS-CoV-2 infection were included. The primary endpoint was in-hospital mortality, secondary endpoints included major complications and modes of death. A multistate analysis and a Cox regression analysis for competing risk models were performed. Modes of death were determined by two independent reviewers. Between February 25, and May 8, 213 patients were included in the analysis. The median age was 65 years, 129 patients (61%) were male. 70 patients (33%) were admitted to the intensive care unit (ICU), of which 57 patients (81%) received mechanical ventilation and 23 patients (33%) ECMO support. Using multistate methodology, the estimated probability to die within 90 days after COVID-19 onset was 24% in the whole cohort. If the levels of care at time of study entry were accounted for, the probabilities to die were 16% if the patient was initially on a regular ward, 47% if in the intensive care unit (ICU) and 57% if mechanical ventilation was required at study entry. Age ≥65 years and male sex were predictors for in-hospital death. Predominant complications-as judged by two independent reviewers-determining modes of death were multi-organ failure, septic shock and thromboembolic and hemorrhagic complications. In a dynamic care model COVID-19-related in-hospital mortality remained very high. In the absence of potent antiviral agents, strategies to alleviate or prevent the identified complications should be investigated. In this context, multistate analyses enable comparison of models-of-care and treatment strategies and allow estimation and allocation of health care resources.
Sections du résumé
BACKGROUND
Reported mortality of hospitalised Coronavirus Disease-2019 (COVID-19) patients varies substantially, particularly in critically ill patients. So far COVID-19 in-hospital mortality and modes of death under state of the art care have not been systematically studied.
METHODS
This retrospective observational monocenter cohort study was performed after implementation of a non-restricted, dynamic tertiary care model at the University Medical Center Freiburg, an experienced acute respiratory distress syndrome (ARDS) and extracorporeal membrane-oxygenation (ECMO) referral center. All hospitalised patients with PCR-confirmed SARS-CoV-2 infection were included. The primary endpoint was in-hospital mortality, secondary endpoints included major complications and modes of death. A multistate analysis and a Cox regression analysis for competing risk models were performed. Modes of death were determined by two independent reviewers.
RESULTS
Between February 25, and May 8, 213 patients were included in the analysis. The median age was 65 years, 129 patients (61%) were male. 70 patients (33%) were admitted to the intensive care unit (ICU), of which 57 patients (81%) received mechanical ventilation and 23 patients (33%) ECMO support. Using multistate methodology, the estimated probability to die within 90 days after COVID-19 onset was 24% in the whole cohort. If the levels of care at time of study entry were accounted for, the probabilities to die were 16% if the patient was initially on a regular ward, 47% if in the intensive care unit (ICU) and 57% if mechanical ventilation was required at study entry. Age ≥65 years and male sex were predictors for in-hospital death. Predominant complications-as judged by two independent reviewers-determining modes of death were multi-organ failure, septic shock and thromboembolic and hemorrhagic complications.
CONCLUSION
In a dynamic care model COVID-19-related in-hospital mortality remained very high. In the absence of potent antiviral agents, strategies to alleviate or prevent the identified complications should be investigated. In this context, multistate analyses enable comparison of models-of-care and treatment strategies and allow estimation and allocation of health care resources.
Identifiants
pubmed: 33180830
doi: 10.1371/journal.pone.0242127
pii: PONE-D-20-25207
pmc: PMC7660518
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0242127Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Science. 2020 May 1;368(6490):476-477
pubmed: 32327600
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
BMC Med Res Methodol. 2020 Aug 11;20(1):206
pubmed: 32781984
Ann Intern Med. 2020 Aug 18;173(4):268-277
pubmed: 32374815
Crit Care. 2020 Jun 2;24(1):282
pubmed: 32487260
Lancet Neurol. 2020 Sep;19(9):767-783
pubmed: 32622375
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
BMJ. 2020 May 22;369:m1985
pubmed: 32444460
Intensive Care Med. 2020 Jul;46(7):1502-1503
pubmed: 32435823
N Engl J Med. 2020 May 21;382(21):2049-2055
pubmed: 32202722
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Thromb Haemost. 2020 Jul;18(7):1743-1746
pubmed: 32320517
Lancet Respir Med. 2020 May;8(5):430-432
pubmed: 32272081
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
Stat Methods Med Res. 2002 Apr;11(2):91-115
pubmed: 12040698
Lancet Infect Dis. 2020 Aug;20(8):e192-e197
pubmed: 32539990
Intensive Care Med. 2020 Jun;46(6):1105-1108
pubmed: 32347323
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
ASAIO J. 2020 Jul;66(7):707-721
pubmed: 32604322
Crit Care Med. 2020 Sep;48(9):e799-e804
pubmed: 32452888
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528